The 8^th annual ChinaBio^® Partnering Forum 2016 life science partnering event will return to Suzhou, China, May 18–19. Suzhou is an active biopharma hub and the home of international and China pharmaceutical and medical companies. China is now the world’s second largest and fastest growing major pharma market, and the event will bring together biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies to capitalize on this high-growth potential. More than 858 delegates from 435 companies and 22 countries attended last year's Partnering Forum, making it the largest partnering conference in China.

“China is transforming into an innovation-based economy,” said Greg B. Scott, Founder of ChinaBio® Group. “Suzhou BioBay has aggressively fostered innovation in medical devices, pharmaceuticals, and diagnostics, as well as research-related services. Many of the companies as well as companies from all over China are eager to partner with western companies.”

Hengrui, a leading developer of novel cancer therapeutics in China, is a regular attendee and presenter at ChinaBio® Partnering Forum. “At ChinaBio®, we meet many companies from here in China as well as from the US and Europe, and we can discuss possible collaborations to help bring new medicines to the market,” said Lianshan Zhang, PhD, President of Global R&D at Hengrui.

Innovative companies, organizations and researchers interested in partnering their technologies or products, initiating strategic alliances, or tapping into the financing network in China may apply to present at the event.

Partnering meetings will be managed by partneringONE®, EBD Group’s sophisticated, web-based partnering system that enables event delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative startups.

Attendees may register before March 18, 2016 to save $200 of the regular registration fee.

About ChinaBio® Group:

Since its founding in 2007, ChinaBio® Group has successfully helped nearly 100 US, European and Asia-Pacific life science companies achieve success in China. Leveraging their consulting and advisory teams’ significant experience in China’s life science industry, ChinaBio has helped its clients identify over 1,000 in-/out-licensing and M&A opportunities and raise over $500M in funding in China. ChinaBio’s clients have included many global pharma and life science companies as well as early stage and mid-size companies in Europe and the US. ChinaBio has also organized over 30 conferences in China focused on investment and partnering, and publishes ChinaBio® Today, the most widely read source for China life science news. ChinaBio® Group is headquartered in Shanghai with staff in San Diego, Silicon Valley, Canada and Switzerland. More information is available at www.chinabio.com

Contact:

Jean Meng
ChinaBio^® Group
780 Cailun Road, #822
Shanghai 201203 China
From China: +86 21 5137 0751
From USA: +1 858 859 1860
Jean.Meng@chinabio.com